These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Therapeutic platelet transfusion versus routine prophylactic transfusion in patients with haematological malignancies: an open-label, multicentre, randomised study. Wandt H; Schaefer-Eckart K; Wendelin K; Pilz B; Wilhelm M; Thalheimer M; Mahlknecht U; Ho A; Schaich M; Kramer M; Kaufmann M; Leimer L; Schwerdtfeger R; Conradi R; Dölken G; Klenner A; Hänel M; Herbst R; Junghanss C; Ehninger G; Lancet; 2012 Oct; 380(9850):1309-16. PubMed ID: 22877506 [TBL] [Abstract][Full Text] [Related]
9. Haematological cancer: Prophylactic platelet transfusion is frequently not necessary. Schiffer CA Nat Rev Clin Oncol; 2013 Aug; 10(8):431-2. PubMed ID: 23820637 [No Abstract] [Full Text] [Related]
10. Thrombocytopenia and platelet transfusions in patients with cancer. Valent J; Schiffer CA Cancer Treat Res; 2011; 157():251-65. PubMed ID: 21052961 [TBL] [Abstract][Full Text] [Related]
11. Platelets--to transfuse or not to transfuse. Blumberg N; Heal JM; Phillips GL; Phipps RP Lancet; 2012 Oct; 380(9850):1287-9. PubMed ID: 22877505 [No Abstract] [Full Text] [Related]
13. Compliance with prophylactic platelet transfusion trigger in haematological patients. Eikenboom JC; van Wordragen R; Brand A Transfus Med; 2005 Feb; 15(1):45-8. PubMed ID: 15713128 [TBL] [Abstract][Full Text] [Related]
14. Platelet transfusion prophylaxis for patients with haematological malignancies: where to now? Stanworth SJ; Hyde C; Brunskill S; Murphy MF Br J Haematol; 2005 Dec; 131(5):588-95. PubMed ID: 16351634 [TBL] [Abstract][Full Text] [Related]
15. Platelet transfusion goals in oncology patients. Fasano RM; Josephson CD Hematology Am Soc Hematol Educ Program; 2015; 2015():462-70. PubMed ID: 26637759 [TBL] [Abstract][Full Text] [Related]
16. Platelet transfusions for patients with haematological malignancies: who needs them? Estcourt LJ; Stanworth SJ; Murphy MF Br J Haematol; 2011 Aug; 154(4):425-40. PubMed ID: 21615375 [TBL] [Abstract][Full Text] [Related]
17. Interventions to reduce platelet prophylactic transfusions in patients with hypoproliferative thrombocytopenia: providing patients with the full benefit. Vamvakas EC; Hitzler WE Clin Lab; 2013; 59(5-6):459-64. PubMed ID: 23865342 [TBL] [Abstract][Full Text] [Related]
18. Real-time ultrasound-guided central venous catheterization reduces the need for prophylactic platelet transfusion in thrombocytopenic patients with hematological malignancy. Tomoyose T; Ohama M; Yamanoha A; Masuzaki H; Okudaira T; Tokumine J Transfus Apher Sci; 2013 Oct; 49(2):367-9. PubMed ID: 23083962 [No Abstract] [Full Text] [Related]
19. An audit of platelet transfusion within the Wellington Cancer Centre. Buhrkuhl DC; Karlsson MK; Carter JM Intern Med J; 2012 Jan; 42(1):65-70. PubMed ID: 21040321 [TBL] [Abstract][Full Text] [Related]
20. Platelets photochemically treated with amotosalen HCl and ultraviolet A light correct prolonged bleeding times in patients with thrombocytopenia. Slichter SJ; Raife TJ; Davis K; Rheinschmidt M; Buchholz DH; Corash L; Conlan MG Transfusion; 2006 May; 46(5):731-40. PubMed ID: 16686840 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]